Dextera

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Dextera and buy or sell other stocks, ETFs, and their options commission-free!

About DXTRQ

Dextera Surgical, Inc. designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. It specializes in robotic-assisted surgery and medical devices. 

CEO
Kala Swaminathan
CEOKala Swaminathan
Employees
Employees
Headquarters
San Mateo, California
HeadquartersSan Mateo, California
Founded
1997
Founded1997
Employees
Employees

DXTRQ Key Statistics

Market cap
1.60M
Market cap1.60M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
143.69K
Average volume143.69K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.148
52 Week high$0.148
52 Week low
$0.0165
52 Week low$0.0165

Stock Snapshot

With a market cap of 1.6M, Dextera(DXTRQ) trades at $0.03. The stock has a price-to-earnings ratio of -0.02.

On 2026-05-16, Dextera(DXTRQ) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Dextera(DXTRQ) stock has reached 0, versus its average volume of 143.69K.

Over the past 52 weeks, Dextera(DXTRQ) stock has traded between a high of $0.15 and a low of $0.02.

Over the past 52 weeks, Dextera(DXTRQ) stock has traded between a high of $0.15 and a low of $0.02.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.